Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Tomone Shioura"'
Autor:
Yutaka Yoshioka, Masatoshi Hayashi, Mochihito Suzuki, Naoki Ishiguro, Yosuke Hattori, Takuya Matsumoto, Takefumi Kato, Yachiyo Kuwatsuka, Yasuhide Kanayama, Tsuyoshi Nishiume, Hisato Ishikawa, Tomone Shioura, Toki Takemoto, Tomonori Kobayakawa, Yuji Hirano, Shuji Asai, Nobuyuki Asai, Masahiko Ando, Yuichiro Yabe, Masahiro Hanabayashi, Yasumori Sobue, Toshihisa Kojima, Takayoshi Fujibayashi, Nobunori Takahashi
Publikováno v:
Revue du Rhumatisme. 88:354-361
Resume Objectif Etudier les facteurs predictifs de poussee de polyarthrite rhumatoide (PR) apres arret du methotrexate chez des patients japonais presentant une faible activite stable de la maladie sous traitement combine de tocilizumab (TCZ) et meth
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3aca75a637d3aec421683b3badbcdb69
https://doi.org/10.1016/j.rhum.2021.05.005
https://doi.org/10.1016/j.rhum.2021.05.005
Autor:
Yachiyo Kuwatsuka, Hisato Ishikawa, Yasumori Sobue, Takuya Matsumoto, Yutaka Yoshioka, Toshihisa Kojima, Mochihito Suzuki, Tomone Shioura, Yosuke Hattori, Toki Takemoto, Takefumi Kato, Yuichiro Yabe, Yuji Hirano, Masatoshi Hayashi, Shuji Asai, Tomonori Kobayakawa, Masahiko Ando, Takayoshi Fujibayashi, Naoki Ishiguro, Nobunori Takahashi, Nobuyuki Asai, Yasuhide Kanayama, Masahiro Hanabayashi, Tsuyoshi Nishiume
Publikováno v:
Joint bone spine. 87(6)
Objective To investigate predictors of disease flare after methotrexate discontinuation in Japanese rheumatoid arthritis (RA) patients with sustained low disease activity undergoing tocilizumab plus methotrexate combination therapy. Methods Participa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::404a6d66e30f41c572726f3b0d6143f8
https://pubmed.ncbi.nlm.nih.gov/32534200
https://pubmed.ncbi.nlm.nih.gov/32534200
Autor:
Hideki Takagi, Takayoshi Fujibayashi, Atsushi Kaneko, Nobunori Takahashi, Takayasu Ito, Toshihisa Kojima, Tomone Shioura, Daihei Kida, Takeshi Oguchi, Takefumi Kato, Koji Funahashi, Hiroyuki Miyake, Masatoshi Hayashi, Naoki Ishiguro, Yuji Hirano, Yasuhide Kanayama, Hisato Ishikawa, Yuichiro Yabe, Yosuke Hattori
Publikováno v:
Modern Rheumatology. 28:119-125
This study aimed to determine whether serum matrix metalloproteinase-3 (MMP-3) levels can predict remission in rheumatoid arthritis (RA) patients treated with adalimumab (ADA).Subjects were 114 RA patients continuously treated with ADA for 52 weeks.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6594122a0a081e74ac4dde3c8623e04
https://doi.org/10.1080/14397595.2017.1317320
https://doi.org/10.1080/14397595.2017.1317320
Autor:
Yutaka Yoshioka, Masatoshi Hayashi, Tomonori Kobayakawa, Mochihito Suzuki, Yuichiro Yabe, Takuya Matsumoto, Masahiro Hanabayashi, Nobuyuki Asai, Toshihisa Kojima, Yasuhide Kanayama, Naoki Ishiguro, Tsuyoshi Nishiume, Yosuke Hattori, Toki Takemoto, Tomone Shioura, Yachiyo Kuwatsuka, Yasumori Sobue, Yuji Hirano, Shuji Asai, Masahiko Ando, Takefumi Kato, Takayoshi Fujibayashi, Nobunori Takahashi, Hisato Ishikawa
Publikováno v:
Modern rheumatology. 30(3)
Objectives: To evaluate the efficacy and safety of methotrexate (MTX) discontinuation in Japanese rheumatoid arthritis (RA) patients with sustained low disease activity undergoing combinati...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::396686094fa76bc05b360d24385e372b
https://pubmed.ncbi.nlm.nih.gov/31390271
https://pubmed.ncbi.nlm.nih.gov/31390271
Autor:
Taiji Matsuyama, Seiji Tsuboi, Tomone Shioura, Hiroshi Yamada, Yui Tazoe, Kunihiko Itoh, Daiki Tsuji, Kazuyuki Inoue, Tadashi Sugiyama, Keita Hirai, Hideki Hayashi
Publikováno v:
Drug Metabolism and Pharmacokinetics. 30:227-230
Responsiveness to methotrexate (MTX), the “anchor drug” for treating rheumatoid arthritis (RA), varies among individual patients. In this study we investigated the effects of folate transporter gene expression levels on disease activity among 56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e040c52323090cd71559e91828595383
https://doi.org/10.1016/j.dmpk.2015.02.001
https://doi.org/10.1016/j.dmpk.2015.02.001
Autor:
Tomone Shioura, Naoki Ishiguro, Masahiro Hanabayashi, Koji Funahashi, Atsushi Kaneko, Yuji Hirano, Toshihisa Kojima, Shuji Asai, S. Hirabara, Yasuhide Kanayama, Tomonori Kobayakawa, Masatoshi Hayashi, Yuichiro Yabe, Nobuyuki Asai, Kiwamu Saito, Nobunori Takahashi, Hiroyuki Miyake
Publikováno v:
Modern Rheumatology. 25:251-256
The purpose of this study was to explore drug retention rates of second biologic agents after switching from tumor necrosis factor inhibitors (TNFi) in clinical practice in patients with rheumatoid arthritis (RA) on low-dose methotrexate (MTX) or wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::da06767ab20ce465b888d2f500095f33
https://doi.org/10.3109/14397595.2014.953668
https://doi.org/10.3109/14397595.2014.953668
Autor:
Shuji Asai, Masatoshi Hayashi, Masahiro Hanabayashi, Yasuhide Kanayama, Toki Takemoto, Yuichiro Yabe, Tomone Shioura, Hisato Ishikawa, Yutaka Yoshioka, Takefumi Kato, Yuji Hirano, Takayoshi Fujibayashi, Yosuke Hattori, Tomonori Kobayakawa, Masahiko Ando, Yachiyo Kuwatsuka, Nobunori Takahashi, Takuya Matsumoto, Nobuyuki Asai, Yasumori Sobue
Publikováno v:
Modern Rheumatology; May 2020, Vol. 30 Issue 3, p434-441, 8p
Autor:
Seiji Tsuboi, Tomone Shioura, Taiji Matsuyama, Motohiro Ohshima, Hideki Hayashi, Hirotaka Nishiyama, Kunihiko Itoh
Publikováno v:
Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 39:388-393
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8084f85e77970b95cd1e8df16433a8c4
https://doi.org/10.5649/jjphcs.39.388
https://doi.org/10.5649/jjphcs.39.388
Autor:
Takefumi Kato, Tomone Shioura, H. Matsubara, Koji Funahashi, Yuji Hirano, Daizo Kato, Yosuke Hattori, Hisato Ishikawa, Tsuyoshi Wanatabe, Toshihisa Kojima, Atsushi Kaneko, Daihei Kida, Masatoshi Hayashi, Hiroyuki Miyake, Hiroki Tsuchiya, Hideki Takagi, Nobuyuki Asai, Nobunori Takahashi, Kenya Terabe, Yuichiro Yabe, Naoki Ishiguro
Publikováno v:
Modern Rheumatology. 23:977-985
The inflammatory cytokine interleukin-6 (IL-6) directly stimulates C-reactive protein (CRP) expression. The present study aimed to examine how clinical treatment outcomes of rheumatoid arthritis (RA) with tocilizumab (TCZ), a humanised monoclonal ant
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3ecce05d211270b228ae33e686b9943f
https://doi.org/10.1007/s10165-012-0782-y
https://doi.org/10.1007/s10165-012-0782-y
Autor:
Kenya Terabe, Naoki Ishiguro, Naoki Fukaya, Daizo Kato, Atsushi Kaneko, Masatoshi Hayashi, Hisato Ishikawa, Koji Funahashi, Takefumi Kato, Yuji Hirano, Hiroyuki Miyake, H. Matsubara, Hiroki Tsuchiya, Hideki Takagi, Toshihisa Kojima, Yuichiro Yabe, Tomone Shioura
Publikováno v:
Modern Rheumatology. 22:370-375
The goal of treating rheumatoid arthritis (RA) should be remission, for which a new definition was proposed in 2011. To determine which patients can achieve the new Boolean-based definition of remission in clinical practice, we analyzed factors assoc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7cf38cc8f2d957f293fa9e529620ef4
https://doi.org/10.3109/s10165-011-0528-2
https://doi.org/10.3109/s10165-011-0528-2